In addition, it was reported that some acute myeloid leukemia cells depend on an efficient CHK1-mediated replication stress response for viability, and therapeutic strategies that inhibit CHK1 may extend current cytarabine-based treatments and overcome drug resistance 40. The gene discussed is CHEK1; the disease is acute myeloid leukemia.